Vera Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 952 | 635 | ||
EBITDA | -44,672 | -31,796 | -27,429 | -27,161 |
EBIT | -44,696 | -33,291 | -26,477 | -26,526 |
Net Income | -46,632 | -33,708 | -28,383 | -25,655 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -61,994 | -24,782 | -33,830 | -25,207 |
Cash | 27,256 | 25,085 | 69,105 | 45,681 |
Basic Shares | 54,898 | 54,728 | 50,971 | 44,452 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,862 | $0 | $0 | $0 |
Gross Profit | 1,862 | 846 | -176 | -251 |
EBITDA | -102,012 | -91,749 | -34,226 | -52,995 |
EBIT | -102,012 | -90,903 | -34,402 | -53,246 |
Net Income | -95,990 | -89,056 | -32,609 | -53,413 |
Net Change In Cash | 1,862 | 0 | 0 | 0 |
Cost of Revenue | -36,215 | 25,970 | ||
Free Cash Flow | -92,244 | -67,658 | -23,708 | -34,908 |
Cash | 45,681 | 114,653 | 79,674 | 53,654 |
Basic Shares | 42,707 | 26,570 | 21,277 | 3,708 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.85 |
2024-06-30 | -$0.62 |
2024-03-31 | -$0.56 |
2023-12-31 | -$0.60 |
